HIV-associated anal cancer
File(s)
Published version
Author(s)
Newsom-Davis, T
Bower, M
Type
Journal Article
Abstract
HIV-associated anal carcinoma, a non-AIDS-defining cancer, is a human papillomavirus-associated malignancy with a spectrum of preinvasive changes. The standardized incidence ratio for anal cancer in patients with HIV/AIDS is 20-50. Algorithms for anal cancer screening include anal cytology followed by high-resolution anoscopy for those with abnormal findings. Outpatient topical treatments for anal intraepithelial neoplasia include infrared coagulation therapy, trichloroacetic acid, and imiquimod. The development of cost-effective national screening programs for HIV-associated anal cancer remains a challenge.
Date Issued
2010-12-08
Date Acceptance
2010-12-08
Citation
F1000 Medicine Reports, 2010, 2
ISSN
1757-5931
Publisher
Faculty of 1000 Ltd
Journal / Book Title
F1000 Medicine Reports
Volume
2
Copyright Statement
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License
(http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited. You may not use this work for commercial purposes.
(http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited. You may not use this work for commercial purposes.
License URL
Publication Status
Published
Article Number
85